Recent Advances in Breast Cancer Related Lymphedema

On April 19, 2011, the Avon Foundation for Women, in partnership with the Lymphatic Research Foundation and the National Lymphedema Network, assembled a group of leading scientists and clinicians expert in breast cancer-related lymphedema to discuss the advances being made in the early-detection and early-intervention of upper extremity lymphedema, how such advances are improving management of the impairment and the need for clinical standardization of care. Below are resulting materials.


Breast Cancer Related Lymphedema

Breast cancer-related lymphedema (BCRL) is a chronic, debilitating disorder that is frequently misdiagnosed, treated too late or not treated at all. Lymphedema (LE) is an abnormal accumulation of protein-rich fluid in the interstitium, which leads to limb swelling, chronic inflammation and reactive fibrosis of the affected tissues resulting from damage to lymphatic circulation following surgery, chemotherapy and/or radiation therapy. 

For additional resources and information, visit: